Nifty 50
- Infosys₹999.757.75 (0.78%)
- Adani Enterprises₹2,578.40-164.60 (-6.00%)
- Tech Mahindra₹1,497.306.20 (0.42%)
- JSW Steel₹1,178.70-51.30 (-4.17%)
- Titan Company₹4,388.1011.10 (0.25%)
- ITC₹255.25-10.45 (-3.93%)
- Axis Bank₹1,244.902.40 (0.19%)
- Max Healthcare₹872.35-35.65 (-3.93%)
- HCL Technologies₹1,186.701.70 (0.14%)
- InterGlobe Aviation₹4,811-179.00 (-3.59%)
- Trent₹2,891.801.50 (0.05%)
- Adani Ports₹1,690.20-59.90 (-3.42%)
- Apollo Hospitals₹7,651.50-265.50 (-3.35%)
- Bharat Electronics₹367.20-11.10 (-2.93%)
- Tata Motors PV₹274.90-8.10 (-2.86%)
- Shriram Finance₹922.20-25.80 (-2.72%)
- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Margin Pledge Calculator
- Algo Strategy
- Markets
Stocks
F&O
Mutual Funds
- More
Open Free Demat Account
Open Free Demat Account
Marksans Pharma Share Price Today
As of 08-10-2026 15:22, Marksans Pharma Ltd. share price today is ₹0, with a change of ₹-325.45 (-100.00%) from the previous close of ₹325.45. The stock opened at ₹326.1 and traded between ₹304.45 and ₹326.25, with a total traded volume of 2068043 shares. The company has a market capitalization of ₹14700.6 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹350.95 and ₹155, respectively.
Marksans Pharma Ltd. valuation metrics include a P/E ratio of 28.4, EPS of ₹9.22, and book value of ₹4.60. Profitability indicators show ROE of 13.83% along with a dividend yield of 0.3%. Marksans Pharma Ltd. has reported revenue of ₹3171.75 Cr and net profit of ₹516.75 Cr.
Marksans Pharma Ltd. technical indicators include Day RSI at 49.4, Day MFI at 55.35, Day ADX at 21.1. Additional indicators include Commodity Channel Index (CCI) at -11.8 and Williams %R at -60.5. Momentum indicators show Day MACD at 3.97, Day MACD Signal Line at 6.11, DayATR at 14.58. Rate of Change indicators for Marksans Pharma Ltd. include ROC125 at 95.1 and ROC21 at -2.35.
Exponential moving averages include EMA5 at ₹328.5, EMA10 at ₹329.9, EMA12 at ₹330, EMA20 at ₹328.4, EMA26 at ₹326, EMA50 at ₹312.5, EMA100 at ₹284.8, EMA200 at ₹253.7. Simple moving averages include SMA5 at ₹329.3, SMA10 at ₹333.3, SMA20 at ₹330.1, SMA30 at ₹328.9, SMA50 at ₹312.7, SMA100 at ₹281.3, SMA150 at ₹246.6, SMA200 at ₹229.3.
Support levels for Marksans Pharma are placed at First Support ₹317.08, Second Support ₹309.77, Third Support ₹297.33. Resistance levels are seen at First Resistance ₹336.83, Second Resistance ₹349.27, Third Resistance ₹356.58. Marksans Pharma Ltd. shareholding pattern shows promoter holding at 43.87%, FII holding at 17.47%, DII holding at 0%, public holding at 32.46%.
Marksans Pharma Performance
Price Movement
₹304.45
₹326.25
1 Year Performance
₹155.00
₹350.95
Markets Today
Historical Performance
Marksans Pharma Fundamentals
Marksans Pharma Financials
Indicator | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Total Revenue | 321.19 | 361.57 | 339.73 | 320.44 | 319.73 |
| Operating Expense | 239.08 | 255.58 | 264.28 | 248.37 | 249.68 |
| Operating Profit | 82.10 | 105.99 | 75.44 | 72.08 | 70.05 |
| Depreciation | 8.78 | 8.76 | 8.83 | 8.46 | 8.19 |
| Interest | 0.34 | 0.35 | 0.36 | 0.32 | 0.30 |
| Tax | 21.42 | 32.44 | 21.20 | 21.69 | 15.52 |
| Net Profit | 69.04 | 91.92 | 60.91 | 99.81 | 48.06 |
Marksans Pharma Technicals
Marksans Pharma Ltd. EMA & SMA
₹310.00
↗ Bullish Moving Average
7
↘ Bearish Moving Average
9
Marksans Pharma Support and Resistance
Resistance
Support
Technical Indicators
Marksans Pharma Shareholding Pattern
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoter | 43.9 | 43.9 | 43.9 | 43.9 | 43.9 | 43.9 |
| FII | 22.2 | 19.9 | 16.9 | 8.1 | 16.8 | 17.5 |
| DII | 4.5 | 5.5 | 5.3 | 5.9 | 6.5 | 6.2 |
| Public | 29.4 | 30.7 | 33.9 | 42.1 | 32.8 | 32.5 |
Marksans Pharma Delivery And Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 15.23 L | 32.37 L | 47.06% |
| Week | 12.56 L | 27.32 L | 45.96% |
| 1 Month | 10 L | 25.7 L | 38.90% |
| 6 Month | 9.73 L | 33.77 L | 28.81% |
Marksans Pharma SWOT Analysis
Benjamin Graham Value Screen
Strong Performer, Getting Expensive (DVM)
Companies with 10% increase in share price over three months, with rising net profit growth
Consistent high performing stocks over Five Years
Rising Net Cash Flow and Cash from Operating activity
Companies with high TTM EPS Growth
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Increasing profits every quarter for the past 4 quarters
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Near 52 Week High
Highest Recovery from 52 Week Low
Volume Shockers
Stocks near 52 Week High with Significant Volumes
Insiders bought stocks
Stocks Outperforming their Industry Price Change in the Quarter
Marksans Pharma Corporate Action
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 20 Aug, 2026 | 0.9 | FINAL | 20 Aug, 2026 | Equity Share |
| 01 Aug, 2025 | 0.8 | FINAL | 01 Aug, 2025 | Equity Share |
| 17 Sep, 2024 | 0.6 | FINAL | 17 Sep, 2024 | Equity Share |
| 07 Jun, 2023 | 0.5 | FINAL | 07 Jun, 2023 | Equity Share |
| 19 Aug, 2022 | 0.25 | FINAL | Equity Share | |
| 15 Sep, 2021 | 0.25 | FINAL | Equity Share | |
| 22 Sep, 2020 | 0.1 | FINAL | Equity Share | |
| 19 Sep, 2019 | 0.05 | FINAL | Equity Share | |
| 19 Sep, 2018 | 0.05 | FINAL | Equity Share | |
| 19 Sep, 2017 | 0.05 | FINAL | Equity Share |
Marksans Pharma Stock Comparison
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹1,097.40 | ₹1,991.60 | ₹1,124.60 | ₹1,321.50 | ₹1,477 | ₹3,584.90 |
| % Change | -3.36% | -2.43% | -3.91% | -4.90% | -3.38% | -3.71% |
| Revenue TTM (₹ Cr) | - | ₹1,479.07 | ₹675.61 | ₹691.72 | ₹1,543.34 | ₹949.80 |
| Net Profit TTM (₹ Cr) | - | ₹199.03 | ₹182.64 | ₹126.37 | ₹-48.62 | ₹266 |
| PE TTM | - | 62.70 | 71.60 | 50.60 | -362.20 | 32.40 |
| 1 Year Return | 16.35 | 92.09 | 95.35 | 93.38 | -17.96 | -22.12 |
| ROCE | 14.97 | 31.54 | 24.22 | 15.60 | 0.59 | - |
Similar Stocks
AKUMS
Akums Drugs & Pharmaceuticals Ltd.
₹ 788.05
-4.19%
INNOVACAP
Innova Captab Ltd.
₹ 1130.10
-3.10%
BLUEJET
Blue Jet Healthcare Ltd
₹ 519.65
-4.01%
CONCORDBIO
Concord Biotech Ltd.
₹ 1330.00
-2.18%
AARTIPHARM
Aarti Pharmalabs Ltd.
₹ 879.75
-7.72%
SUPRIYA
Supriya Lifescience Ltd.
₹ 859.25
-3.37%
ALIVUS
Alivus Life Sciences Ltd.
₹ 1343.30
-1.96%
COHANCE
Cohance Lifesciences Ltd.
₹ 441.20
-3.13%
ERIS
Eris Lifesciences Ltd.
₹ 1160.50
+1.28%
SYNGENE
Syngene International Ltd.
₹ 346.80
-3.75%
APLLTD
Alembic Pharmaceuticals Ltd.
₹ 803.80
-3.60%
SPARC
Sun Pharma Advanced Research Company Ltd.
₹ 188.96
-3.98%
STAR
Strides Pharma Science Ltd.
₹ 1075.60
-2.27%
FDC
FDC Ltd.
₹ 325.00
-1.08%
JUBLPHARMA
Jubilant Pharmova Ltd.
₹ 935.00
-4.06%
NATCOPHARM
Natco Pharma Ltd.
₹ 801.80
-1.02%
ORCHPHARMA
Orchid Pharma Ltd.
₹ 984.15
-3.89%
IOLCP
IOL Chemicals and Pharmaceuticals Ltd.
₹ 208.94
-5.12%
VIYASH
Viyash Scientific Ltd.
₹ 237.99
-1.15%
ASTRAZEN
AstraZeneca Pharma India Ltd.
₹ 5777.50
-2.37%
BLISSGVS
Bliss GVS Pharma Ltd.
₹ 667.35
-2.08%
SANOFI
Sanofi India Ltd.
₹ 2984.40
-1.30%
PFIZER
Pfizer Ltd.
₹ 3741.60
-1.93%
MOREPENLAB
Morepen Laboratories Ltd.
₹ 139.82
-4.86%
FAQ's on MARKSANS
What is the current share price of Marksans Pharma Ltd.?
What is the Market Capitalization of Marksans Pharma Ltd.?
What are the PE and PB ratios for Marksans Pharma Ltd.?
What is the 52-Week High and Low for Marksans Pharma Ltd.?
What is the current dividend yield for Marksans Pharma Ltd.?
Who are the major shareholders of Marksans Pharma Ltd.?
Who are the peers of Marksans Pharma Ltd. in the Pharmaceuticals & Biotechnology sector?
What is the latest dividend information for Marksans Pharma Ltd.?
Invest Anytime, Anywhere
By signing up I certify terms, conditions & privacy policy